Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- ...

Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically significant and clinically meaningful improvement in prosta ...

Good afternoon, ladies and gentlemen, and welcome to the Inovio First Quarter 2026 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, May 13, 2026. I ...

City reaches tentative settlement with former yogurt shop murder suspects Proposed settlement is $35 million The four men were formally exonerated in February Police say another man, Robert Eugene ...

Dr Craige Golding discusses the concept of immune aging, immunosenescence and inflammaging and why it matters.